26/08/2026
Orbis Diagnostics CEO Cather Simpson recently sat down with BusinessDesk NZ to discuss the company's ambitions to transform medical testing.
From tackling Hepatitis B to its plans for the US market, Cather shares why Orbis has focused on de-risking the commercial and regulatory sides of the business early on.
Read the BusinessDesk article here (paywall): https://businessdesk.co.nz/article/startups/orbis-ceo-early-commercial-derisking-is-key-to-med-tech-companies-success
Orbis is currently raising capital via Snowball. To learn more about investing in Orbis, see: https://www.snowballeffect.co.nz/offers/show/orbis-diagnostics-2026-f0qgh